Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Equity Ratio (2019 - 2026)

BioScience Health Innovations has reported Equity Ratio over the past 8 years, most recently at 0.72 for Q1 2026.

  • Quarterly Equity Ratio fell 20.1% to 0.72 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.72 through Mar 2026, down 20.1% year-over-year, with the annual reading at 0.87 for FY2025, 9.47% down from the prior year.
  • Equity Ratio was 0.72 for Q1 2026 at BioScience Health Innovations, down from 0.87 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.96 in Q4 2024 and troughed at 3.25 in Q1 2023.
  • The 5-year median for Equity Ratio is 0.83 (2025), against an average of 0.38.
  • Year-over-year, Equity Ratio soared 1420.53% in 2024 and then decreased 20.1% in 2026.
  • A 5-year view of Equity Ratio shows it stood at 0.9 in 2022, then tumbled by 108.05% to 0.07 in 2023, then soared by 1420.53% to 0.96 in 2024, then fell by 9.47% to 0.87 in 2025, then dropped by 16.46% to 0.72 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Equity Ratio are 0.72 (Q1 2026), 0.87 (Q4 2025), and 0.83 (Q3 2025).